Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder

Journal of Medical Genetics

Volumn 41, Issue 3, 2004, Pages 219-223

  Papiol, S ^a   Rosa, A ^a   Gutierrez B ^a   Martin B ^a   Salgado, P ^b   Catalan R ^c   Arias, B ^a   Fananas L ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Mental Clinic of Santa Coloma   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFFECTIVE PSYCHOSIS; ARTICLE; BIPOLAR MANIA; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENETIC ANALYSIS; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOAFFECTIVE PSYCHOSIS; TANDEM REPEAT;

EID: 1542511726     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2003.012914     Document Type: Article

References (42)

1. Crow TJ. Con: the demise of the Kraepelinian binary systems as a prelude to genetic advance. In: Gerson ES, Cloninger CR, eds. Genetic approaches to mental disorders. Washington, DC: American Psychiatry Press, 1994:163-92.
2. Crow TJ. From Kraepelin to Kretschmer leavened by Schneider the transition from categories of psychosis to dimensions of variation intrinsic to Homo sapiens. Arch Gen Psychiatry 1998;55:502-4.
3. Kendler KS, Walsh D. The structure of psychosis: syndromes and dimensions. Arch Gen Psychiatry 1998;55:508-9.
4. Kendler KS, Karkowski LM, Walsh D. The structure of psychosis: latent class analysis of probands from the Roscommon Family Study. Arch Gen Psychiatry 1998;55:492-9.
5. Moziode M, Roy MA, Martinez M, Cliche D, Fournier JP, Garneau Y, Nicole L, Montgrain N, Dion C, Ponton AM. Negative psychoticism and disorganised dimensions in patients with familial schizophrenia or bipolar disorder: continuity and discontinuity between major psychoses. Am J Psychiatry 1995;152:1458-63.
6. Elkis H, Friedman L, Wise A, Meltzer HY. Metoanalyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia. Arch Gen Psychiatry 1995;52:735-46.
7. Gutiérrez B, Van Os J, Vallès V, Guillamat R, Campillo M, Fañanás L. Congenital dermatoglyphic malformations in severe bipolar disorder. Psychiatry Res 1998;78:133-40.
8. Bebbington P, Wilkins S, Jones PB, Foerster A, Murray R, Toone B, Lewis S. Life events and psychosis. Initial results from the Camberwell Collaborative Psychosis Study. Br J Psychiatry 1993;162:72-9.
9. Berrettini WH. Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol Psychiatry 2000;48:531-8.
10. Sham PC, Jones P, Russell A, Gilvarry K, Bebbington P, Lewis S, Toone B, Murray R. Age at onset, sex, and familial psychiatric morbidity in schizophrenia. Camberwell Collaborative Psychosis Study. Br J Psychiatry 1994;165:466-73.
11. Vallès V, Van Os J, Guillamat R, Gutiérrez B, Campillo M, Gento P, Fañanás L. Increased morbid risk for schizophrenia in families of in-patients with bipolar illness. Schizophr Res 2000;42:83-90.
12. Gershon ES, Hamovit J, Guroff JJ, Dibble E, Leckman JF, Sceery W, Targum SD, Nurnberger JI, Goldin LR, Bunney WE. A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry 1982;39:1157-67.
13. Weissman MM, Gershon ES, Kidd KK, Prusoff BA, Leckman JF, Dibble E, Hamovit J, Thompson WD, Pauls DL, Guroff JJ. Psychiatric disorders in the relatives of probands with affective disorders. Arch Gen Psychiatry 1984;41:13-21.
14. Katila H, Appelberg B, Hurme M, Rimon R. Plasma levels of interleukin-1beta and interleukin-6 in schizophrenia, other psychosis and affective disorders. Schizophr Res 1994;12:29-34.
15. Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res 1995;29:141-52.
16. Theodoropoulou ST, Spanakos G, Baxevanis CN, Economou M, Gritzapis AD, Papamichail MP, Stefanis CN. Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients. Schizophr Res 2001;47:13-25.
17. Tsai SY, Chen KP, Yang YY, Chen CC, Lee JC, Singh VK, Leu SJ. Activation of indices of cell-mediated immunity in bipolar mania. Biol Psychiatry 1999;45:989-94.
18. Nicklin MJH, Barton JL, Nguyen M, FitzGerald MG, Duff GW, Kornman K. A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics 2002;79:718-25.
19. Haukim N, Bidwell JL, Smith AJ, Keen LJ, Gallagher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D'Alfonso S. Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun 2002;3:313-30.
20. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001;2:734-44.
21. Nawa H, Takahashi M, Patterson PH. Cytokine and growth factor involvement in schizophrenia-support for the developmental model. Mol Psychiatry 2000;5:594-603.
22. Friedman WJ, Thakur S, Seidman L, Rabson AB. Regulation of nerve growth facor mRNA by interleukin-1 in rat hippocampal astrocytes is mediated by NfkappaB. J Biol Chem 1996;271:31115-20.
23. Potter ED, Ling ZD, Carvey PM. Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons. Cell Tissue Res 1999;296:235-46.
24. Arend WR. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 2002;13:323-40.
25. Akiyama K. Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration. Schizophr Res 1999;37:97-106.
26. Katila H, Hänninen K, Hurme M. Polymorphisms of the interleukin-1 gene in schizophrenia. Mol Psychiatry 1999;4:179-81.
27. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 1998;28:2598-602.
28. Santtila S, Savinainen K, Hurme M. Presence of the IL-1Ra allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 1998;47:195-98.
29. Vamvakopoulos J, Green C, Metcalfe S. Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur J Immunol 2002;32:2988-96.
30. Meisenzahl EM, Rujescu D, Kirner A, Giegling I, Kathmann N, Leisinger G, Maag K, Hegerl U, Hahn K, Moller HJ. Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia. Am J Psychiatry 2001;158:1316-19.
31. Rosa A, Peralta V, Papiol S, Cuesta MJ, Serrano F, Martínez- Larrea A, Fañanás L. The effect of the IL-1beta gene in the complex phenotype of psychosis. Am J Med Genet 2002;114:867-8.
32. Endicott J, Andreasen N, Spitzer RL. Family History-Research Diagnostic Criteria. New York: New York State Psychiatric Institute, Biometrics Research, 1975.
33. Goldberg DP, Hillier VF. Scaled version of the General Health Questionnaire. Psychol Med 1979;9:139-45.
34. Schneider S, Kuefer JM, Roessli D, Excoffier L. Arlequin: a software environment for the analysis of population genetics datagenetics and biometry. LabArlequin: a software environment for the analysis of population genetics data. Geneva: Genetics and Biometry Lab, University of Geneva, 1996.
35. Cox A, Camp NJ, Nicklin MJ, di Giovine FS, Duff GW. An analysis of linkage disequilibrium in the interleukin-1 cluster, using a novel grouping method for multiallelic markers. Am J Hum Genet 1998;62:1180-8.
36. Pessi T, Karjalainen J, Hulkkonen J, Nieminen MM, Hurme M. A common IL-1 complex haplotype is associated with an increased risk of atopy. J Med Genet 2003;40:e66.
37. El-Omar EM, Carrington M, Chow W-H, McColl KEL, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Rabkin CS. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
38. Tseng LH, Chen PJ, Lin MT, Shau WY, Chaung SM, Martin PJ, Hansen JA. Single nucleotide polymorphisms in intron 2 of the human interleukin-1 receptor antagonist (IL-11Ra) gene: further definition of the IL-1beta and IL-1Ra polymorphisms in North American Caucasians and Taiwanese Chinese. Tissue Antigens 2001;57:318-24.
39. Tatsumi M, Sasaki T, Sakai T, Kamijima K, Fukuda R, Kunugi H, Hattori M, Nanko S. Genes for interleukin-2 receptor beta chain, interleukin-1beta and schizophrenia: no evidence for the association or linkage. Am J Med Genet 1997;74:338-41.
40. Laurent C, Thibaut F, Ravassard P, Campion D, Samolyk D, Laforgue C, Petit M, Martinez M, Mallet J. Detection of two new polymorphic sites in the human interleukin-1beta gene: lack of association with schizophrenia in a French population. Psychiatr Genet 1997;7:103-5.
41. Yang J, Si T, Ling Y, Ruan Y, Han Y, Wang X, Zhou M, Zhang H, Kong Q, Liu C, Li X, Yu Y, Liu S, Shu L, Ma D, Wie J, Zhang D. Association study between interleukin-1beta gene and schizophrenia. Life Sci 2003;72:3017-21.
42. Williams NM, Preece A, Spurlock G, Norton N, Williams HJ, Zammit S, O'Donovan MC, Owen MJ. Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol Psychiatry 2003;8:485-87.